{"id":"https://openalex.org/W1968565337","doi":"https://doi.org/10.1007/s11064-014-1293-3","title":"On the Discovery and Development of Pimavanserin: A Novel Drug Candidate for Parkinson\u2019s Psychosis","display_name":"On the Discovery and Development of Pimavanserin: A Novel Drug Candidate for Parkinson\u2019s Psychosis","publication_year":2014,"publication_date":"2014-03-29","ids":{"openalex":"https://openalex.org/W1968565337","doi":"https://doi.org/10.1007/s11064-014-1293-3","mag":"1968565337","pmid":"https://pubmed.ncbi.nlm.nih.gov/24682754","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4172996"},"language":"en","primary_location":{"id":"doi:10.1007/s11064-014-1293-3","doi":"https://doi.org/10.1007/s11064-014-1293-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11064-014-1293-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11064-014-1293-3.pdf","source":{"id":"https://openalex.org/S174790897","display_name":"Neurochemical Research","issn_l":"0364-3190","issn":["0364-3190","1573-6903"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurochemical Research","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s11064-014-1293-3.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053715653","display_name":"Uli Hacksell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Uli Hacksell","raw_affiliation_strings":["ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Ste. 100, San Diego, CA, 92121, USA, uli@acadia-pharm.com","ACADIA Pharmaceuticals, Inc, San Diego, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Ste. 100, San Diego, CA, 92121, USA, uli@acadia-pharm.com","institution_ids":["https://openalex.org/I125377440"]},{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, USA","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053279288","display_name":"Ethan S. Burstein","orcid":"https://orcid.org/0000-0003-1120-9099","observed_orcids":["https://orcid.org/0000-0003-1120-9099"]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ethan S. Burstein","raw_affiliation_strings":["ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Ste. 100, San Diego, CA, 92121, USA","ACADIA Pharmaceuticals, Inc, San Diego, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Ste. 100, San Diego, CA, 92121, USA","institution_ids":["https://openalex.org/I125377440"]},{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, USA","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012594959","display_name":"Krista McFarland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Krista McFarland","raw_affiliation_strings":["ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Ste. 100, San Diego, CA, 92121, USA","ACADIA Pharmaceuticals, Inc, San Diego, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Ste. 100, San Diego, CA, 92121, USA","institution_ids":["https://openalex.org/I125377440"]},{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, USA","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003930471","display_name":"Roger Mills","orcid":"https://orcid.org/0000-0002-3993-4180","observed_orcids":["https://orcid.org/0000-0002-3993-4180"]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roger G. Mills","raw_affiliation_strings":["ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Ste. 100, San Diego, CA, 92121, USA","ACADIA Pharmaceuticals, Inc, San Diego, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Ste. 100, San Diego, CA, 92121, USA","institution_ids":["https://openalex.org/I125377440"]},{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, USA","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5104349049","display_name":"Hilde Williams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hilde Williams","raw_affiliation_strings":["ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Ste. 100, San Diego, CA, 92121, USA","ACADIA Pharmaceuticals, Inc, San Diego, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Ste. 100, San Diego, CA, 92121, USA","institution_ids":["https://openalex.org/I125377440"]},{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, USA","institution_ids":["https://openalex.org/I125377440"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5053715653"],"corresponding_institution_ids":["https://openalex.org/I125377440"],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":{"value":4590,"currency":"USD","value_usd":4590},"fwci":1.5283,"has_fulltext":true,"cited_by_count":305,"citation_normalized_percentile":{"value":0.81914119,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"39","issue":"10","first_page":"2008","last_page":"2017"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.451200008392334,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.451200008392334,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.41819998621940613,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.043299999088048935,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pimavanserin","display_name":"pimavanserin","score":1.0},{"id":"https://openalex.org/keywords/parkinson-s-disease-psychosis","display_name":"Parkinson's disease psychosis","score":0.996999979019165},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9049999713897705},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.9120000004768372},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.5440000295639038},{"id":"https://openalex.org/keywords/lead-optimization","display_name":"lead optimization","score":0.796999990940094},{"id":"https://openalex.org/keywords/high-throughput-screening","display_name":"high-throughput screening","score":0.718999981880188},{"id":"https://openalex.org/keywords/g-protein-coupled-receptors","display_name":"G protein-coupled receptors","score":0.75},{"id":"https://openalex.org/keywords/motor-symptoms","display_name":"motor symptoms","score":0.5009999871253967},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.5049999952316284},{"id":"https://openalex.org/keywords/off-label-antipsychotic-use","display_name":"off-label antipsychotic use","score":0.6570000052452087}],"concepts":[{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.624732494354248},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.6210293173789978},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6045801639556885},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.5812415480613708},{"id":"https://openalex.org/C89951826","wikidata":"https://www.wikidata.org/wiki/Q1671731","display_name":"Inverse agonist","level":4,"score":0.5772268176078796},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5601584315299988},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5219930410385132},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3995281457901001},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3098052144050598},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2845577597618103},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.2660525143146515},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.18352532386779785}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014508","descriptor_name":"Urea","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014508","descriptor_name":"Urea","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014508","descriptor_name":"Urea","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1007/s11064-014-1293-3","doi":"https://doi.org/10.1007/s11064-014-1293-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11064-014-1293-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11064-014-1293-3.pdf","source":{"id":"https://openalex.org/S174790897","display_name":"Neurochemical Research","issn_l":"0364-3190","issn":["0364-3190","1573-6903"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurochemical Research","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3145308","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4172996","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4172996","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4172996","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurochem Res","raw_type":"Text"},{"id":"pmid:24682754","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24682754","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurochemical research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s11064-014-1293-3","doi":"https://doi.org/10.1007/s11064-014-1293-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11064-014-1293-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11064-014-1293-3.pdf","source":{"id":"https://openalex.org/S174790897","display_name":"Neurochemical Research","issn_l":"0364-3190","issn":["0364-3190","1573-6903"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurochemical Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1968565337.pdf","grobid_xml":"https://content.openalex.org/works/W1968565337.grobid-xml"},"referenced_works_count":48,"referenced_works":["https://openalex.org/W86074418","https://openalex.org/W162223338","https://openalex.org/W1513119389","https://openalex.org/W1569349971","https://openalex.org/W1822227732","https://openalex.org/W1916235480","https://openalex.org/W1964179714","https://openalex.org/W1967630951","https://openalex.org/W1972576882","https://openalex.org/W1981706712","https://openalex.org/W1991337007","https://openalex.org/W1991426892","https://openalex.org/W1992139786","https://openalex.org/W1994147209","https://openalex.org/W1996609417","https://openalex.org/W2000375438","https://openalex.org/W2012024748","https://openalex.org/W2013289991","https://openalex.org/W2013937696","https://openalex.org/W2017068519","https://openalex.org/W2020339143","https://openalex.org/W2026136738","https://openalex.org/W2035090655","https://openalex.org/W2043704385","https://openalex.org/W2048944183","https://openalex.org/W2054789315","https://openalex.org/W2061749100","https://openalex.org/W2074146160","https://openalex.org/W2082868177","https://openalex.org/W2084336343","https://openalex.org/W2094743762","https://openalex.org/W2102142981","https://openalex.org/W2107881620","https://openalex.org/W2125458229","https://openalex.org/W2134583432","https://openalex.org/W2141619916","https://openalex.org/W2150063374","https://openalex.org/W2153641048","https://openalex.org/W2155427998","https://openalex.org/W2161441546","https://openalex.org/W2168822710","https://openalex.org/W2301648017","https://openalex.org/W2312629800","https://openalex.org/W2327877878","https://openalex.org/W2473999118","https://openalex.org/W2789913401","https://openalex.org/W4239283954","https://openalex.org/W4255901800"],"related_works":["https://openalex.org/W2529311995","https://openalex.org/W1967630951","https://openalex.org/W7221332622","https://openalex.org/W2056703646","https://openalex.org/W45020151","https://openalex.org/W2766632734","https://openalex.org/W2047004456","https://openalex.org/W2061320396","https://openalex.org/W2980209530","https://openalex.org/W4229508902"],"abstract_inverted_index":{"Parkinson's":[0,16,299],"disease":[1,300],"psychosis":[2],"(PDP)":[3],"is":[4,19,316],"a":[5,20,85,103,129,147,186,231,252,327],"condition":[6],"that":[7,93,128,314],"may":[8,324],"develop":[9,165],"in":[10,56,76,141,176,211,224,241,257,262],"up":[11],"to":[12,68,114,164,226],"60":[13],"%":[14],"of":[15,41,84,88,106,179,214,249],"patients,":[17],"and":[18,72,151,158,197,216,218,277,286,288,305,318],"major":[21],"reason":[22],"for":[23,27,36,192,247,255,331],"nursing":[24],"home":[25],"placement":[26],"those":[28],"affected.":[29],"There":[30],"are":[31,46],"no":[32,198],"FDA":[33],"approved":[34],"drugs":[35,44],"PDP":[37],"but":[38,60],"low":[39],"doses":[40],"atypical":[42,107,111],"anti-psychotic":[43],"(APDs)":[45],"commonly":[47],"prescribed":[48],"off-label.":[49],"Only":[50],"low-dose":[51,118],"clozapine":[52,119],"has":[53,311],"shown":[54],"efficacy":[55,265],"randomized":[57],"controlled":[58],"trials,":[59],"all":[61,263],"APDs":[62,112,228],"have":[63],"black":[64],"box":[65],"warnings":[66],"related":[67],"the":[69,110,177,227,242,245,297],"increased":[70],"mortality":[71],"morbidity":[73],"when":[74],"used":[75,113],"elderly":[77],"demented":[78],"patients.":[79],"Using":[80],"molecular":[81],"pharmacological":[82],"profiling":[83],"large":[86],"collection":[87],"marketed":[89],"drugs,":[90],"we":[91],"discovered":[92],"potent":[94],"inverse":[95,134,170,189],"agonist":[96,135],"activity":[97,200,210],"against":[98],"5-HT2A":[99,132,168,187,193],"serotonin":[100],"receptors":[101],"was":[102,126,172],"common":[104],"feature":[105],"APDs,":[108],"especially":[109],"treat":[115],"PDP.":[116,258,335],"Since":[117],"therapy":[120],"selectively":[121],"blocks":[122],"this":[123],"receptor,":[124],"it":[125],"hypothesized":[127],"highly":[130,238],"selective":[131,167],"receptor":[133,169,188],"might":[136],"provide":[137],"good":[138,284],"symptom":[139],"control":[140],"patients":[142,332],"suffering":[143,333],"from":[144,334],"PDP,":[145,217],"with":[146,320],"greatly":[148],"improved":[149],"safety":[150,285],"tolerability":[152,287],"profile.":[153],"A":[154],"high":[155],"throughput":[156],"screening":[157],"subsequent":[159],"chemical":[160],"lead":[161],"optimization":[162],"campaign":[163],"potent,":[166],"agonists":[171],"launched,":[173],"eventually":[174],"resulting":[175],"discovery":[178],"pimavanserin.":[180],"Pimavanserin":[181,282,323],"displays":[182],"nanomolar":[183],"potency":[184],"as":[185,294],"agonist,":[190],"selectivity":[191],"over":[194],"5-HT2C":[195],"receptors,":[196],"meaningful":[199],"at":[201],"any":[202],"other":[203,264],"G-protein":[204],"coupled":[205],"receptor.":[206],"It":[207],"demonstrated":[208,283,313],"robust":[209],"preclinical":[212],"models":[213],"schizophrenia":[215],"did":[219,289],"not":[220,290],"worsen":[221,291],"motoric":[222,292],"symptoms,":[223],"contrast":[225],"tested.":[229],"In":[230,259],"Phase":[232],"III":[233],"clinical":[234,269],"trial,":[235],"pimavanserin":[236,315],"showed":[237],"significant":[239],"benefits":[240],"primary":[243],"endpoint,":[244],"scale":[246,253,302],"assessment":[248],"positive":[250],"symptoms-PD,":[251],"adapted":[254],"use":[256],"addition,":[260],"improvements":[261],"endpoints,":[266],"including":[267],"physician's":[268],"global":[270],"impression,":[271],"caregiver":[272],"burden,":[273],"night-time":[274],"sleep":[275],"quality":[276],"daytime":[278],"wakefulness,":[279],"were":[280],"seen.":[281],"symptoms":[293],"assessed":[295],"by":[296],"unified":[298],"rating":[301],"parts":[303],"II":[304],"III.":[306],"An":[307],"open-label":[308],"extension":[309],"study":[310],"further":[312],"safe":[317],"well-tolerated":[319],"long-term":[321],"use.":[322],"therefore":[325],"offer":[326],"viable":[328],"treatment":[329],"option":[330]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":14},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":15},{"year":2022,"cited_by_count":19},{"year":2021,"cited_by_count":18},{"year":2020,"cited_by_count":168},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":5}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}